NEW YORK CITY, NY / ACCESS Newswire / December 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RxSight, Inc. ("RxSight" or "the Company") (NASDAQ:RXST). Investors who purchased RxSight securities prior to November 7, 2024, and continue to hold to the present, are encouraged to obtain additional […]
NEW YORK CITY, NY / ACCESS Newswire / December 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bicycle Therapeutics plc ("Bicycle" or "the Company") (NASDAQ:BCYC). Investors who purchased Bicycle securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/BCYC.
NEW YORK CITY, NY / ACCESS Newswire / December 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jasper Therapeutics, Inc. ("Jasper" or "the Company") (NASDAQ:JSPR). Investors who purchased Jasper securities prior to November 30, 2023, and continue to hold to the present, are encouraged to obtain
NEW YORK CITY, NY / ACCESS Newswire / December 28, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Jayud Global Logistics Ltd. ("Jayud" or the "Company") (NASDAQ:JYD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / December 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are
NEW YORK CITY, NY / ACCESS Newswire / December 28, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Primo Brands Corporation ("Primo Brands" or the "Company") (NYSE:PRMB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK, NY / ACCESS Newswire / December 28, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (NYSE:INSP) securities. If you suffered a loss on your Inspire Medical Systems, Inc. investment and would like
The following is the text of an email sent today to all IBM employees by Chairman and CEO Arvind Krishna: https://mma.prnewswire.com/media/2852128/IBM_Lou_Gertsner.jpg IBMers, I am saddened to share that Lou Gerstner, IBM's Chairman and CEO from 1993 to 2002, passed away yesterday. Lou arrived at IBM at a moment when the company's future was genuinely uncertain.
NEW YORK, NY / ACCESS Newswire / December 28, 2025 / Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation ("Xoma" or the "Company") (NASDAQ: XOMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Xoma and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / December 28, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Cogent Communications Holdings, Inc. ("Cogent" or the "Company") (NASDAQ: CCOI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Cogent and certain of its officers